Prosecution Insights
Last updated: August 18, 2026

Foundation Medicine Inc.

17 pending office actions • 5 art units • 14 examiners • 0 of 17 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days

Portfolio Summary

17
Total Pending OAs
13
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

11
Hard (65%)
4
Medium (24%)
2
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (12%)
§101 + other6 (35%)
§103 only4 (24%)
Double-patenting only2 (12%)
Multi-statute (no §101)3 (18%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
59% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
6% of docket
6
Business / Other
35% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

170 h
Manual time on pending OAs
34 h
Time saved (low, 20%)
59 h
Time saved (mid, 35%)
1.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
VANNI, GEORGE STEVEN 3 67.2% +24.5%
KIM, YOUNG J 2 64.8% +18.0%
NGUYEN, TRAN N 1 61.9% +16.9%
KALLAL, ROBERT JAMES 1 60.6% +33.7%
ALLEN, KYLA GUAN-PING TI 1 89.9% +15.6%
PATEL, PINALBEN V 1 88.9% +9.9%
KOROMA, SORIE IBRAHIM 1
SALMON, KATHERINE D 1 42.6% +38.0%
JOHANNSEN, DIANA B 1 53.3% +42.5%
SITTON, JEHANNE SOUAYA 1 53.0% +48.0%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18924829 METHODS AND SYSTEMS FOR MACHINE LEARNING-BASED PREDICTION OF GENE ALTERATIONS FROM PATHOLOGY IMAGES ALLEN, KYLA GUAN-PING TI
18915180 METHODS AND SYSTEMS FOR COMPUTATIONAL SEX DETERMINATION FROM HISTOLOGIC SECTIONS PATEL, PINALBEN V

Hard Cases (11)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
16579500 SYSTEM AND METHOD FOR MANAGING GENOMIC INFORMATION WOITACH, JOSEPH T 99d overdue
17746712 PRECISION ENRICHMENT OF PATHOLOGY SPECIMENS SANFORD, DIANA PATRICIA 31d overdue
19103529 METHODS AND SYSTEMS FOR DETECTION OF MISMATCH REPAIR DEFICIENCY NGUYEN, TRAN N
19020349 METHODS AND SYSTEMS FOR DETERMINING CIRCULATING TUMOR DNA FRACTION IN A PATIENT SAMPLE KALLAL, ROBERT JAMES
18910993 SYSTEMS AND METHODS FOR PREDICTING SLIDE-LEVEL CLASS LABELS FOR A WHOLE-SLIDE IMAGE KOROMA, SORIE IBRAHIM
18712646 METHODS AND SYSTEMS FOR REPORTING CLINICALLY-ACTIONABLE POTENTIAL GERMLINE PATHOGENIC VARIANT SEQUENCES KIM, YOUNG J
18276223 BIOMARKERS FOR CANCER TREATMENT SALMON, KATHERINE D
18274675 METHODS AND SYSTEMS FOR CHARACTERIZING AND TREATING COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA VANNI, GEORGE STEVEN

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18025365 METHODS OF DETECTING AN INACTIVATING MUTATION OF PBRM1 IN MENINGIOMA SITTON, JEHANNE SOUAYA 18d overdue
19171081 SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION VANNI, GEORGE STEVEN
19103529 METHODS AND SYSTEMS FOR DETECTION OF MISMATCH REPAIR DEFICIENCY NGUYEN, TRAN N
19020349 METHODS AND SYSTEMS FOR DETERMINING CIRCULATING TUMOR DNA FRACTION IN A PATIENT SAMPLE KALLAL, ROBERT JAMES
18924829 METHODS AND SYSTEMS FOR MACHINE LEARNING-BASED PREDICTION OF GENE ALTERATIONS FROM PATHOLOGY IMAGES ALLEN, KYLA GUAN-PING TI
18722508 DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW KIM, YOUNG J
18712646 METHODS AND SYSTEMS FOR REPORTING CLINICALLY-ACTIONABLE POTENTIAL GERMLINE PATHOGENIC VARIANT SEQUENCES KIM, YOUNG J
18276223 BIOMARKERS FOR CANCER TREATMENT SALMON, KATHERINE D

Top Art Units

Art UnitApps
1682 4
1686 3
1687 2
3685 1
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19171081 SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION VANNI, GEORGE STEVEN 1686 DP Non-Final OA Pending Apr 04, 2025
19103529 METHODS AND SYSTEMS FOR DETECTION OF MISMATCH REPAIR DEFICIENCY NGUYEN, TRAN N 3685 §101§102§103 Non-Final OA Pending Feb 12, 2025
19020349 METHODS AND SYSTEMS FOR DETERMINING CIRCULATING TUMOR DNA FRACTION IN A PATIENT SAMPLE KALLAL, ROBERT JAMES 1685 §101 Non-Final OA Pending Jan 14, 2025
18924829 METHODS AND SYSTEMS FOR MACHINE LEARNING-BASED PREDICTION OF GENE ALTERATIONS FROM PATHOLOGY IMAGES ALLEN, KYLA GUAN-PING TI §103 Non-Final OA Pending Oct 23, 2024
18915180 METHODS AND SYSTEMS FOR COMPUTATIONAL SEX DETERMINATION FROM HISTOLOGIC SECTIONS PATEL, PINALBEN V §103 Non-Final OA Pending Oct 14, 2024
18910993 SYSTEMS AND METHODS FOR PREDICTING SLIDE-LEVEL CLASS LABELS FOR A WHOLE-SLIDE IMAGE KOROMA, SORIE IBRAHIM §103§112 Non-Final OA Pending Oct 09, 2024
18722508 DETECTION OF GENETIC AND EPIGENETIC INFORMATION IN A SINGLE WORKFLOW KIM, YOUNG J §103 Non-Final OA Pending Jun 20, 2024
18712646 METHODS AND SYSTEMS FOR REPORTING CLINICALLY-ACTIONABLE POTENTIAL GERMLINE PATHOGENIC VARIANT SEQUENCES KIM, YOUNG J §101§102§103§112 Non-Final OA Pending May 22, 2024
18276223 BIOMARKERS FOR CANCER TREATMENT SALMON, KATHERINE D 1682 §103§112 Non-Final OA Pending Aug 07, 2023
18274675 METHODS AND SYSTEMS FOR CHARACTERIZING AND TREATING COMBINED HEPATOCELLULAR CHOLANGIOCARCINOMA VANNI, GEORGE STEVEN §101 Non-Final OA Pending Jul 27, 2023
18037309 COMPREHENSIVE GENOMIC PROFILING (CGP) OF METASTATIC INVASIVE LOBULAR CARCINOMAS REVEALS HETEROGENEITY JOHANNSEN, DIANA B 1682 §103§112 Non-Final OA Pending May 16, 2023
18025365 METHODS OF DETECTING AN INACTIVATING MUTATION OF PBRM1 IN MENINGIOMA SITTON, JEHANNE SOUAYA 1682 §103 Final Rejection 18d overdue Pending Mar 08, 2023
18008410 METHODS AND SYSTEMS FOR DISTINGUISHING SOMATIC GENOMIC SEQUENCES FROM GERMLINE GENOMIC SEQUENCES PLAYER, ROBERT AUSTIN 1686 §101§103DP Final Rejection Pending Dec 05, 2022
17746712 PRECISION ENRICHMENT OF PATHOLOGY SPECIMENS SANFORD, DIANA PATRICIA 1687 §101§102§103§112 Final Rejection 31d overdue Pending May 17, 2022
17774452 METHODS OF DETECTING A FUSION GENE ENCODING A NEOANTIGEN VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §101§103Other Non-Final OA Pending May 04, 2022
17612966 SYSTEMS AND METHODS FOR EVALUATING TUMOR FRACTION VANNI, GEORGE STEVEN 1686 DP Non-Final OA Pending Nov 19, 2021
16579500 SYSTEM AND METHOD FOR MANAGING GENOMIC INFORMATION WOITACH, JOSEPH T 1687 §101§103§112DP Final Rejection 99d overdue Pending Sep 23, 2019

Managing Foundation Medicine Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month